Acetazolamide
- Product NDC
- 69367-209
- 11-digit product format
- 693670209
- Labeler code
- 69367
- Product ID
- 69367-209_c04410c8-e55f-4f15-a10d-9d94476bde16
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Westminster Pharmaceuticals, LLC
- Application
- ANDA090779
- Marketing category
- ANDA
- Marketing start
- 2023-04-20
- Marketing end
- 2028-05-01
- Substance
- ACETAZOLAMIDE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 500 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 562524 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69367-209-01 | Acetazolamide | 100 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 100 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69367-209 | ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE [WESTMINSTER PHARMACEUTICALS, LLC] | 2 | Current NDC, 1 package rows | 20250328_417b1df2-63bc-473c-9e02-5f93dd45554d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69367-209-01 | 69367020901 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69367-209-01) | 2023-04-20 | 2028-05-01 | No | No | Historical |